Medibio Limited
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more
Medibio Limited (MDBIF) - Total Liabilities
Latest total liabilities as of June 2025: $831.22K USD
Based on the latest financial reports, Medibio Limited (MDBIF) has total liabilities worth $831.22K USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medibio Limited - Total Liabilities Trend (2001–2025)
This chart illustrates how Medibio Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medibio Limited Competitors by Total Liabilities
The table below lists competitors of Medibio Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CONOCOPHILLIPS - Dusseldorf Stock Exchang
DU:YCP
|
Germany | €46.82 Billion |
|
Cascadero Copper Corporation
PINK:CCEDF
|
USA | $561.17K |
|
Thai Mui Corporation Public Company Limited
BK:THMUI
|
Thailand | ฿299.98 Million |
|
ADP - Dusseldorf Stock Exchang
DU:W7L
|
Germany | €14.36 Billion |
|
CWTH BK AUSTRALIA
MU:CWW
|
Germany | €1.18 Trillion |
|
Cosmo Metals Ltd
AU:CMO
|
Australia | AU$587.56K |
|
Advent Technologies Holdings Inc
NASDAQ:ADN
|
USA | $24.46 Million |
Liability Composition Analysis (2001–2025)
This chart breaks down Medibio Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medibio Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medibio Limited (2001–2025)
The table below shows the annual total liabilities of Medibio Limited from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $831.22K | -29.20% |
| 2024-06-30 | $1.17 Million | -30.48% |
| 2023-06-30 | $1.69 Million | +22.21% |
| 2022-06-30 | $1.38 Million | +43.39% |
| 2021-06-30 | $963.68K | -31.37% |
| 2020-06-30 | $1.40 Million | -70.12% |
| 2019-06-30 | $4.70 Million | -7.46% |
| 2018-06-30 | $5.08 Million | -14.46% |
| 2017-06-30 | $5.94 Million | -37.03% |
| 2016-06-30 | $9.43 Million | +55.21% |
| 2015-06-30 | $6.07 Million | +160.41% |
| 2014-06-30 | $2.33 Million | -19.04% |
| 2013-06-30 | $2.88 Million | -4.99% |
| 2012-06-30 | $3.03 Million | +44.43% |
| 2011-06-30 | $2.10 Million | +574.97% |
| 2010-06-30 | $311.02K | +18.60% |
| 2009-06-30 | $262.24K | -47.24% |
| 2008-06-30 | $497.07K | +176.43% |
| 2007-06-30 | $179.82K | -2.26% |
| 2006-06-30 | $183.98K | -23.21% |
| 2005-06-30 | $239.59K | -13.49% |
| 2004-06-30 | $276.96K | -3.70% |
| 2003-06-30 | $287.58K | -68.49% |
| 2002-06-30 | $912.54K | -4.12% |
| 2001-06-30 | $951.79K | -- |